Convatec Group PLC

Report Publication Announcement • Mar 30, 2022

National Storage Mechanism | Additional information

RNS Number : 6102G

ConvaTec Group PLC

30 March 2022

Publication of Annual Report and Accounts 2021

and Notice of Meeting

READING, UNITED KINGDOM (30 March 2022) - ConvaTec Group Plc ("ConvaTec" or the "Group"), a global medical products and technologies company, today announces that the following documents are now available on its website at www.convatecgroup.com.

-      Annual Report and Accounts 2021

-      Notice of Annual General Meeting

-      Form of Proxy

In compliance with Listing Rule 9.6.1, copies of the Annual Report and Accounts 2021,  Notice of Annual General Meeting and Form of Proxy, will be submitted to the National Storage Mechanism and will, in due course, be available for inspection at https://data.fca.org.uk/#/nsm/nationalstoragemechanism.

Printed copies of these documents will be sent to shareholders who have requested hard copies in due course.

Enquiries

Analysts and Investors

Kate Postans, VP Investor Relations, ConvaTec                   +44 (0)782 644 7807

ir@convatec.com

Media

Buchanan: Charles Ryland / Chris Lane                                  +44 (0)207 466 5000                                                                                                                         

ConvaTec Group Plc's LEI code is 213800LS272L4FIDOH92

About ConvaTec

ConvaTec is a global medical products and technologies company focused on solutions for the management of chronic conditions, with leading market positions in advanced wound care, ostomy care, continence and critical care, and infusion care. Our products provide a range of clinical and economic benefits including infection prevention, protection of at-risk skin, improved patient outcomes and reduced total cost of care. To learn more about ConvaTec, please visit www.convatecgroup.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

ACSKZGFFGGNGZZM